Search filters

List of works by Vince B C Biemans

A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients

scientific article published on 27 April 2020

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study

scientific article published on 09 September 2020

Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.

scientific article published on 9 January 2018

Editorial: is age just a number when it comes to treatment of inflammatory bowel disease? Authors' reply

scientific article published on 01 November 2020

Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy

scientific article published on 15 May 2020

Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply

scientific article published on 01 October 2020

Letter: ustekinumab's effectiveness compared with vedolizumab in Crohn's disease-what about mucosal healing and biomarkers? Authors' reply

scientific article published on 01 August 2020

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

scientific article published on 01 April 2020

Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?

scientific article published on 08 July 2020

Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

scientific article published on 01 January 2020

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment

scientific article published on 22 May 2020

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

scientific article published on 01 January 2020

Paulina is supported by:

About Paulina

Help